Navigation Links
Shortage of Drug for Children's Cancer May Have Upped Relapse Rates
Date:12/27/2012

By Serena Gordon
HealthDay Reporter

WEDNESDAY, Dec. 26 (HealthDay News) -- When a national shortage of a cancer drug that had helped treat children with Hodgkin's lymphoma for decades forced doctors to find a substitute, they thought they had settled on a drug that would work just as well for these young cancer patients.

But a new analysis suggests they were mistaken.

Mechlorethamine, also known as nitrogen mustard, had been part of a common chemotherapy regimen for Hodgkin's since the 1960s, but experts believed the drug cyclophosphamide would perform equally well. The statistics in the analysis tell another story, however, with two-year remission rates dropping from 88 percent to 75 percent after the switch was made.

"We thought this would be an easy substitution. Cyclophosphamide has been used forever for Hodgkin's lymphoma," said analysis co-author Dr. Monica Metzger, an associate member of the department of oncology at St. Jude Children's Research Hospital in Memphis, Tenn. "We thought the equivalent dose would work just as well, but it doesn't work the same in this chemotherapy regimen. More patients relapsed."

"There are many treatments that work very well. Both mechlorethamine and cyclophosphamide are efficacious, but once you begin a regimen of medications, you have to follow the whole regimen," Metzger said. "It's like a recipe. Like any other recipe, it calls for certain ingredients, and if you make a substitution, you get different results."

The original chemotherapy regimen for Hodgkin's lymphoma, dubbed MOPP, included mechlorethamine, vincristine, procarbazine and prednisone. This combination of drugs was effective, but it also was linked to secondary leukemia and infertility.

Since then, other chemotherapy combinations have been developed to help lessen the side effects. In an effort to further improve outcomes for those with Hodgkin's lymphoma, a newer regimen called Stanford
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Drug shortage linked to greater risk of relapse in young Hodgkin lymphoma patients
2. Fentanyl Injection Shortages Reported: Severe Adverse Events as AttorneyOne Informs
3. Study Foresees Shortage of Primary-Care Doctors
4. Nurse practitioners: The right prescription to ease doctor shortage
5. $3.4 million HHS grant to help UIC address shortage of Latino health providers
6. Canada needs national approach to protect against drug shortages
7. Brain power shortage
8. AFARs MSTAR program addresses shortage of geriatric medicine physicians
9. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. Dr. Gary McClain of JustGotDiagnosed.com Addresses Prostate Cancer Support Group
11. US cancer screening rates decline over the last 10 years, finds new study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Shortage of Drug for Children's Cancer May Have Upped Relapse Rates 
(Date:4/18/2014)... discovery that turns 160 years of neuroanatomy on its ... to be essential for the fast transmission of impulses ... ubiquitous as thought, according to a new work lead ... Institute (HSCI) and the University,s Department of Stem Cell ... of Harvard,s Department of Molecular and Cellular Biology. , ...
(Date:4/18/2014)... Two Simon Fraser University psychologists have made a ... treatment of attention-deficit disorders. , This discovery opens ... may hinder or suppress a specific brain activity ... prevent distraction. , The Journal of Neuroscience ... discovery by John McDonald, an associate professor of ...
(Date:4/17/2014)... inflammation in benign prostate tissue was associated with ... was found even in those with low prostate-specific ... in Cancer Epidemiology, Biomarkers & Prevention , ... Research. , An analysis of prostate tissue biopsies ... of the Prostate Cancer Prevention Trial (PCPT) found ...
(Date:4/17/2014)... vaccine brands for children may not be the most ... factors when choosing vaccines, driving the market toward what ... new study by University of Illinois researchers. , "The ... numerous factors," says Sheldon H. Jacobson, a co-author of ... of mathematics at the U. of I. "In an ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2
... Cheresh, PhD, professor of pathology at the University of ... for translational research at the Moores UCSD Cancer Center, ... Award, the highest prize bestowed by the Metastasis Research ... involving metastasis. Cheresh was honored at a recent ...
... study published in the Journal of Sexual Medicine ... experience sexual problems after breast cancer. The results showed ... approximately two years post diagnosis. Mary Panjari, PhD, of ... the sexual well-being nearly two years after diagnosis and ...
... into the hearts of patients who have severe aortic stenosis ... has been found to both save lives and improve the ... to be published online at 2 p.m. Pacific time today ... The study will also be presented at 8 a.m. Pacific ...
... By Serena Gordon HealthDay Reporter , ... and Drug Administration on Wednesday approved the first oral ... system disorder that has traditionally been treated with injectable ... and delay the progression of debilitating symptoms in patients ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... sick to withstand surgery to treat a narrowed aortic valve, ... alive, researchers say. As many as 300,000 Americans suffer ... valve from fully opening and sending blood back into the ...
... 21, 2010 Chicago The prevalence of periodontal ... than originally estimated. Research published in the Journal ... Control and Prevention (CDC) and the American Academy of ... may have been underestimated by as much as 50 ...
Cached Medicine News:Health News:David Cheresh receives top award for cancer metastasis research 2Health News:New treatment for severe aortic stenosis shown to save lives, Stanford researchers say 2Health News:New treatment for severe aortic stenosis shown to save lives, Stanford researchers say 3Health News:FDA Approves 1st Oral Drug to Reduce MS Relapses 2Health News:FDA Approves 1st Oral Drug to Reduce MS Relapses 3Health News:New Procedure for Aortic Valve Replacement Looks Promising 2Health News:New Procedure for Aortic Valve Replacement Looks Promising 3Health News:Gum disease found to be significant public health concern 2
(Date:1/14/2014)... 14, 2014 The Brandeis Medical Center, led by Dr. ... premier and affordable laser tattoo removal experience with the advanced Astanza ... in providing high quality cosmetic services with cutting edge medical technology ... Southern California has seen a dramatic increase in ...
(Date:1/14/2014)... Animal Emergency Critical Care, a LifeCentre partner practice, located at ... is the first in Loudoun County to ... Susan M. Barnes , Medical Director, is a well-seasoned veterinarian ... Cole Taylor , are avid scuba divers. "As altitude skiers and ...
(Date:1/14/2014)... 2014   Oligomerix, Inc. , a privately held company ... disease (AD) and related neurodegenerative disorders, announced today the ... NY as of January 15, 2014 and ... York Medical College. Oligomerix, which is focused ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... , , PRINCETON, N.J. , ... (Soligenix or the Company), a late-stage biotechnology company, announced today ... which addresses its Lipid Polymer Micelle (LPM™) technology for the ... patent, HK 1071054, entitled "Stabilized Reverse Micelle Compositions and ...
... , , SANTA ROSA, Calif. , ... has completed its first Osseoplasty™ procedures in Europe . The ... its European distributor MBA Incorporado, SL, the largest independent medical device ... begin in the next weeks in the United Kingdom , ...
Cached Medicine Technology:Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology 2Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology 3Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology 4Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology 5Osseon Launches in Europe 2
... Density, multi-frequency, linear flexible laparoscopic ... the UST-5536, this "Omni-Plane transducer ... horizontally as well as pivots ... that target lesions can be ...
Super High Density, multi-frequency, end-fire phased array transducer. Point-and-shoot scanning is the benefit of this transducer....
This is a 3D transducer for endovaginal imaging in OB/GYN....
This is a 3D transducer for endovaginal imaging in OB/GYN....
Medicine Products: